A large national study has begun across the UK to understand how best to detect prostate cancer earlier and more accurately. Thousands of men will be invited by their GP to take part, making this the most significant screening research project in many years. The trial is jointly funded by Prostate Cancer UK and the National Institute for Health and Care Research.
The study will explore whether combining rapid MRI scans, PSA blood tests, and new saliva-based genetic tests can improve how effectively aggressive prostate cancers are found—while reducing the number of men who receive unnecessary treatment. Men aged 50–74 will be invited, with the lower age limit reduced to 45 for Black men because of their higher risk.
Participation is by invitation only; men cannot volunteer directly, but those who receive letters are encouraged to take part. Early findings are expected in around two years, with plans to expand the trial further once initial results are analysed.
This comes at a time when national screening recommendations are under review, with many clinicians and patients calling for more reliable early detection methods to prevent late diagnoses and reduce avoidable deaths.
You can read the full BBC News story here:
Biggest prostate cancer screening trial in decades begins in UK (BBC)